WallStreetZenWallStreetZen

NASDAQ: BEAM
Beam Therapeutics Inc Stock Ownership - Who owns Beam Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Beam Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John M. EvansCEO2026-04-0130,078$24.58
$739.32kSell
Bethany J. CavanaghSVP Finance and Treasurer2026-04-013,242$24.58
$79.69kSell
Christine BellonChief Legal Officer2026-04-015,956$24.58
$146.40kSell
Amy SimonChief Medical Officer2026-04-016,700$24.58
$164.69kSell
Giuseppe CiaramellaPresident2026-04-0111,810$24.58
$290.29kSell
John M. EvansCEO2026-03-3125,000$0.67
$16.75kBuy
John M. EvansCEO2026-03-3125,000$22.76
$569.08kSell
John M. EvansCEO2026-03-3025,000$0.67
$16.75kBuy
John M. EvansCEO2026-03-3025,000$22.37
$559.23kSell
Giuseppe CiaramellaPresident2026-02-2435,000$17.00
$595.00kBuy

1 of 4

BEAM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BEAM insiders and whales buy or sell their stock.

BEAM Shareholders

What type of owners hold Beam Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC12.10%12,452,199$333.84MInstitution
Ark Investment Management LLC11.79%12,133,433$325.30MInstitution
Farallon Capital Management LLC9.85%10,134,696$271.71MInstitution
Blackrock Inc8.25%8,487,569$227.55MInstitution
State Street Corp5.54%5,699,265$152.80MInstitution
Fmr LLC4.62%4,752,601$127.42MInsider
Vanguard Portfolio Management LLC4.44%4,570,797$122.54MInstitution
Arch Venture Management LLC4.41%4,540,132$121.72MInstitution
Vanguard Capital Management LLC4.25%4,377,374$117.36MInstitution
Amova Asset Management Americas Inc3.72%3,825,585$102.56MInstitution

1 of 3

BEAM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BEAM86.45%13.55%Net SellingNet Selling
ALMS77.20%22.80%Net Buying
SLNO34.73%65.27%Net SellingNet Selling
TARS73.42%26.58%Net SellingNet Selling
DYN84.14%15.86%Net SellingNet Selling
View Top Biotech Stocks

Beam Therapeutics Stock Ownership FAQ

Who owns Beam Therapeutics?

Beam Therapeutics (NASDAQ: BEAM) is owned by 105.30% institutional shareholders, 16.51% Beam Therapeutics insiders, and 0.00% retail investors. Fmr LLC is the largest individual Beam Therapeutics shareholder, owning 4.75M shares representing 4.62% of the company. Fmr LLC's Beam Therapeutics shares are currently valued at $125.14M.

If you're new to stock investing, here's how to buy Beam Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.